Filing Details

Accession Number:
0001209191-23-057036
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-30 21:52:04
Reporting Period:
2023-11-28
Accepted Time:
2023-11-30 21:52:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1484565 Soleno Therapeutics Inc SLNO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1422484 H James Mackaness 203 Redwood Shores Pkwy, Ste 500
Redwood City CA 94065
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-28 3,205 $27.03 30,365 No 4 S Direct
Common Stock Disposition 2023-11-28 673 $27.59 29,692 No 4 S Direct
Common Stock Disposition 2023-11-29 2,162 $27.43 27,530 No 4 S Direct
Common Stock Disposition 2023-11-29 2,041 $28.26 25,489 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  2. This transaction was executed in multiple trades at prices ranging from $26.465 to $27.46. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  3. This transaction was executed in multiple trades at prices ranging from $27.465 to $28.34. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  4. This transaction was executed in multiple trades at prices ranging from $26.89 to $27.885. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  5. This transaction was executed in multiple trades at prices ranging from $27.89 to $28.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.